Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures

NCT05366621 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.

NCT NCT05366621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures
Lead sponsor
National Cheng-Kung University Hospital
Phase
Observational
Overall status
Completed
Start date
November 1, 2020
Completion date
October 31, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, drug therapy, mortality, osteoporosis, osteoporosis fracture